REGN RSI Chart
Last 7 days
-0.6%
Last 30 days
1.6%
Last 90 days
18.2%
Trailing 12 Months
25.1%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 12.4B | 12.7B | 13.1B | 13.1B |
2022 | 16.5B | 14.2B | 13.5B | 12.2B |
2021 | 9.2B | 12.4B | 13.5B | 16.1B |
2020 | 7.0B | 7.4B | 7.9B | 8.5B |
2019 | 6.6B | 6.5B | 6.6B | 6.6B |
2018 | 6.1B | 6.2B | 6.4B | 6.7B |
2017 | 5.0B | 5.2B | 5.5B | 5.9B |
2016 | 4.4B | 4.6B | 4.7B | 4.9B |
2015 | 3.1B | 3.4B | 3.8B | 4.1B |
2014 | 2.3B | 2.5B | 2.6B | 2.8B |
2013 | 1.6B | 1.7B | 1.9B | 2.1B |
2012 | 565.4M | 762.0M | 1.1B | 1.4B |
2011 | 467.7M | 459.7M | 456.5M | 445.8M |
2010 | 407.8M | 433.7M | 422.2M | 459.1M |
2009 | 0 | 285.4M | 332.3M | 379.3M |
2008 | 0 | 0 | 0 | 238.5M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 14, 2024 | murphy andrew j | sold | -5,531,290 | 956 | -5,783 | evp research |
Mar 13, 2024 | murphy andrew j | acquired | 7,993,200 | 399 | 20,000 | evp research |
Mar 13, 2024 | murphy andrew j | sold (taxes) | -13,816,400 | 971 | -14,217 | evp research |
Mar 01, 2024 | mccourt marion | sold | -346,365 | 967 | -358 | evp commercial |
Mar 01, 2024 | ryan arthur f | sold | -98,205 | 982 | -100 | - |
Feb 26, 2024 | larosa joseph j | sold | -990,000 | 990 | -1,000 | evp general counsel and secret |
Feb 26, 2024 | sing george l | sold | -992,500 | 992 | -1,000 | - |
Feb 26, 2024 | sing george l | acquired | 206,665 | 413 | 500 | - |
Feb 26, 2024 | bassler bonnie l | sold | -836,280 | 979 | -854 | - |
Feb 26, 2024 | stahl neil | gifted | - | - | -1,020 | evp research and development |
Which funds bought or sold REGN recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Mar 14, 2024 | ABLES, IANNONE, MOORE & ASSOCIATES, INC. | new | - | 2,635 | 2,635 | -% |
Mar 13, 2024 | Sivia Capital Partners, LLC | new | - | 238,017 | 238,017 | 0.18% |
Mar 11, 2024 | Wahed Invest LLC | added | 7.31 | 194,594 | 1,534,370 | 0.43% |
Mar 11, 2024 | VANGUARD GROUP INC | added | 0.45 | 521,760,000 | 7,762,580,000 | 0.17% |
Mar 08, 2024 | ICA Group Wealth Management, LLC | new | - | 170,388 | 170,388 | 0.04% |
Mar 08, 2024 | TRUST CO OF VERMONT | reduced | -90.91 | -16,348 | 1,757 | -% |
Mar 06, 2024 | WILLNER & HELLER, LLC | new | - | 332,872 | 332,872 | 0.37% |
Mar 05, 2024 | STONEBRIDGE CAPITAL MANAGEMENT INC | unchanged | - | 41,000 | 646,000 | 0.32% |
Mar 05, 2024 | Fisher Asset Management, LLC | added | 9.17 | 699,084 | 4,938,060 | -% |
Mar 01, 2024 | Pineridge Advisors LLC | new | - | 21,079 | 21,079 | 0.01% |
Unveiling Regeneron Pharmaceuticals Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Date Filed | Form Type | Document | |
---|---|---|---|
Peers (Alternatives to Regeneron Pharmaceuticals Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 39.7B | 6.8B | -8.42 | 5.79 | ||||
HILS | 22.4B | 152.6K | -2.4K | 146.8K | ||||
ALNY | 18.8B | 1.8B | -42.7 | 10.28 | ||||
BMRN | 15.8B | 2.4B | 94.39 | 6.54 | ||||
INCY | 13.1B | 3.7B | 21.93 | 3.55 | ||||
MID-CAP | ||||||||
APLS | 6.8B | 396.6M | -12.94 | 17.25 | ||||
BBIO | 4.8B | - | -7.42 | 60.35 | ||||
AXSM | 3.6B | 270.6M | -14.96 | 13.22 | ||||
ARWR | 3.5B | 240.7M | -11.8 | 14.55 | ||||
ACAD | 3.0B | 726.4M | -49.68 | 4.19 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 398.2M | 26.52 | 4.76 | ||||
NVAX | 740.4M | 983.7M | -1.36 | 0.75 | ||||
CRBP | 458.3M | 881.7K | -10.28 | 530.54 | ||||
INO | 250.8M | 4.9M | -1.86 | 51.53 | ||||
IBIO | 3.7M | 2.1M | -0.13 | 2.14 |
Regeneron Pharmaceuticals Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | 2.1% | 3,434 | 3,363 | 3,158 | 3,162 | 3,414 | 2,936 | 2,897 | 2,857 | 2,965 | 4,952 | 3,453 | 5,139 | 2,529 | 2,423 | 2,294 | 1,952 | 1,828 | 1,864 | 1,744 | 1,578 | 1,373 |
Costs and Expenses | 9.3% | 2,461 | 2,252 | 2,142 | 2,215 | 2,268 | 1,713 | - | 1,747 | 1,707 | 2,312 | 1,606 | 1,791 | 1,416 | 1,256 | 1,241 | 1,296 | 1,128 | 1,188 | 1,005 | 1,262 | 893 |
S&GA Expenses | 15.2% | 738 | 641 | 652 | 601 | 661 | 529 | - | 476 | 450 | 560 | 445 | 415 | 406 | 304 | 327 | 348 | 367 | 452 | 304 | 295 | 291 |
R&D Expenses | 9.5% | 1,177 | 1,075 | 1,085 | 1,101 | 1,043 | 911 | - | 794 | 844 | 738 | 665 | 714 | 743 | 657 | 685 | 722 | 584 | 552 | 526 | 886 | 486 |
EBITDA Margin | -3.5% | 0.36* | 0.37* | 0.41* | 0.41* | 0.43* | 0.50* | 0.49* | 0.47* | 0.57* | 0.60* | 0.62* | 0.61* | 0.51* | 0.48* | 0.47* | 0.47* | 0.40* | 0.41* | 0.37* | 0.35* | 0.41* |
Interest Expenses | 2.8% | 18.00 | 18.00 | 19.00 | 18.00 | 17.00 | 15.00 | - | 13.00 | 14.00 | 14.00 | 14.00 | 14.00 | 15.00 | 15.00 | 26.00 | 10.00 | 6.00 | 7.00 | 8.00 | 8.00 | 8.00 |
Income Taxes | -111.7% | -12.00 | 103 | 115 | 40.00 | 128 | 194 | - | 111 | 88.00 | 274 | 184 | 654 | 138 | 75.00 | 156 | 22.00 | 44.00 | 98.00 | 99.00 | 32.00 | 85.00 |
Earnings Before Taxes | 3.3% | 1,148 | 1,111 | 1,083 | 858 | 1,325 | 1,510 | - | 963 | 1,061 | 2,503 | 1,817 | 3,753 | 1,253 | 1,225 | 998 | 919 | 669 | 890 | 769 | 225 | 546 |
EBT Margin | -4.2% | 0.32* | 0.33* | 0.38* | 0.37* | 0.40* | 0.47* | 0.47* | 0.45* | 0.55* | 0.58* | 0.59* | 0.58* | 0.48* | 0.45* | 0.44* | 0.44* | 0.36* | 0.37* | 0.33* | 0.32* | 0.38* |
Net Income | 15.1% | 1,160 | 1,008 | 968 | 818 | 1,197 | 1,316 | - | 852 | 974 | 2,229 | 1,632 | 3,099 | 1,115 | 1,149 | 842 | 897 | 625 | 792 | 670 | 193 | 461 |
Net Income Margin | -1.1% | 0.30* | 0.30* | 0.34* | 0.34* | 0.36* | 0.42* | 0.42* | 0.40* | 0.48* | 0.50* | 0.52* | 0.50* | 0.44* | 0.41* | 0.40* | 0.40* | 0.33* | 0.32* | 0.32* | 0.32* | 0.37* |
Free Cashflow | -2.2% | 1,090 | 1,114 | 1,022 | 1,368 | 1,720 | 629 | 564 | 564 | 2,102 | 2,373 | 3,414 | 627 | 669 | 1,231 | -254 | 943 | 698 | 787 | 557 | 188 | 897 |
Balance Sheet | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Assets | 2.9% | 33,080 | 32,163 | 30,658 | 30,060 | 29,215 | 27,678 | 27,206 | 26,349 | 25,435 | 23,672 | 21,486 | 17,772 | 17,163 | 16,084 | 14,429 | 15,758 | 14,805 | 13,939 | 13,174 | 12,855 | 11,735 |
Current Assets | 4.5% | 19,479 | 18,635 | 16,923 | 16,909 | 15,884 | 15,429 | 15,530 | 14,306 | 14,015 | 13,775 | 13,338 | 10,055 | 9,779 | 9,098 | 7,860 | 8,644 | 7,689 | 7,109 | 6,651 | 6,929 | 6,448 |
Cash Equivalents | 26.8% | 2,730 | 2,152 | 1,937 | 3,916 | 3,106 | 3,491 | 3,395 | 3,346 | 2,886 | 3,432 | 2,072 | 1,438 | 2,207 | 1,573 | 1,992 | 2,208 | 1,630 | 1,385 | 1,046 | 1,709 | 1,480 |
Inventory | 0.7% | 2,581 | 2,562 | 2,508 | 2,425 | 2,402 | 2,412 | 2,219 | 1,992 | 1,951 | 2,054 | 1,984 | 2,165 | 1,917 | 1,802 | 1,641 | 1,481 | 1,416 | 1,344 | 1,317 | 1,209 | 1,151 |
Net PPE | - | - | - | - | - | - | 3,704 | 3,638 | 3,556 | 3,482 | 3,396 | 3,359 | 3,263 | 3,222 | 3,138 | 3,031 | 2,945 | 2,890 | 2,771 | 2,677 | 2,613 | 2,576 |
Liabilities | -2.1% | 7,107 | 7,259 | 6,640 | 6,565 | 6,551 | 6,239 | 6,518 | 6,434 | 6,666 | 6,414 | 6,359 | 5,795 | 6,138 | 5,959 | 5,371 | 3,625 | 3,716 | 3,435 | 3,418 | 3,410 | 2,977 |
Current Liabilities | -4.9% | 3,423 | 3,599 | 3,104 | 3,100 | 3,141 | 2,879 | 3,034 | 3,008 | 3,933 | 3,715 | 3,732 | 3,218 | 2,697 | 2,338 | 3,702 | 2,055 | 2,097 | 1,765 | 1,713 | 1,511 | 1,443 |
Long Term Debt | 0.0% | 1,983 | 1,983 | 1,982 | 1,982 | 1,981 | 1,981 | 1,981 | 1,980 | 1,980 | 1,980 | 1,979 | 1,979 | 1,979 | 1,978 | - | - | - | - | - | - | - |
LT Debt, Non Current | 0.0% | 1,983 | 1,983 | 1,982 | 1,982 | 1,981 | 1,981 | 1,981 | 1,980 | 1,980 | 1,980 | 1,979 | 1,979 | 1,979 | 1,978 | - | - | - | - | - | - | - |
Shareholder's Equity | 4.3% | 25,973 | 24,904 | 24,018 | 23,495 | 22,664 | 21,439 | 20,688 | 19,915 | 18,769 | 17,258 | 15,127 | 11,977 | 11,025 | 10,126 | 9,057 | 12,133 | 11,090 | 10,504 | 9,756 | 9,445 | 8,757 |
Retained Earnings | 4.4% | 27,260 | 26,101 | 25,093 | 24,125 | 23,307 | 22,110 | 20,794 | 19,942 | 18,968 | 16,739 | 15,107 | 12,008 | 10,893 | 9,744 | 8,902 | 8,004 | 7,380 | 6,588 | 5,918 | 5,725 | 5,254 |
Additional Paid-In Capital | 0.9% | 11,354 | 11,252 | 10,889 | 10,598 | 9,949 | 9,518 | 9,120 | 8,754 | 8,088 | 7,919 | 7,226 | 6,888 | 6,716 | 6,593 | 6,263 | 5,211 | 4,429 | 4,388 | 4,264 | 4,161 | 3,912 |
Shares Outstanding | 0.4% | 107 | 106 | 107 | 107 | 107 | 107 | 107 | 107 | 106 | 106 | 105 | 105 | 108 | 106 | 110 | 110 | 109 | 109 | 109 | 109 | 108 |
Float | - | - | - | 76,700 | - | - | - | 62,000 | - | - | - | 57,065 | - | - | - | 63,344 | - | - | - | 32,929 | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Cashflow From Operations | -2.2% | 1,090 | 1,114 | 1,022 | 1,368 | 1,720 | 629 | 564 | 2,102 | 2,373 | 3,414 | 627 | 669 | 1,231 | -254 | 943 | 698 | 787 | 557 | 188 | 897 | 729 |
Share Based Compensation | 17.9% | 240 | 204 | 202 | 239 | 232 | 166 | 160 | 167 | 188 | 137 | 146 | 131 | 122 | 101 | 104 | 106 | 134 | 117 | 106 | 108 | 127 |
Cashflow From Investing | 86.7% | -66.20 | -496 | -2,386 | -235 | -1,857 | 192 | -413 | -1,705 | -2,012 | -2,438 | 126 | -1,059 | -305 | -775 | 1,453 | -443 | -208 | -207 | -836 | -776 | -265 |
Cashflow From Financing | -9.5% | -446 | -407 | -614 | -322 | -247 | -725 | -101 | 65.00 | -906 | 385 | -118 | -366 | -305 | 612 | -2,612 | 336 | -345 | -11.00 | -15.30 | 120 | -83.00 |
Buy Backs | -40.8% | 300 | 507 | 723 | 694 | 428 | 913 | 394 | 352 | 855 | 191 | 289 | 324 | 360 | 100 | 5,072 | 336 | 247 | 19.00 | - | 10.00 | - |
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME - USD ($) shares in Millions, $ in Millions | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Revenues: | |||
Revenue from contract with customer | $ 13,117.2 | $ 12,172.9 | $ 16,071.7 |
Expenses: | |||
Research and development | 4,439.0 | 3,592.5 | 2,860.1 |
Acquired in-process research and development | 186.1 | 255.1 | 48.0 |
Selling, general, and administrative | 2,631.3 | 2,115.9 | 1,824.9 |
Other operating (income) expense, net | (2.1) | (89.9) | (45.6) |
Total expenses | 9,070.1 | 7,434.0 | 7,124.9 |
Income from operations | 4,047.1 | 4,738.9 | 8,946.8 |
Other income (expense): | |||
Other income (expense), net | 225.2 | 179.3 | 436.3 |
Interest expense | (73.0) | (59.4) | (57.3) |
Total other income (expense) | 152.2 | 119.9 | 379.0 |
Income before income taxes | 4,199.3 | 4,858.8 | 9,325.8 |
Income tax expense | 245.7 | 520.4 | 1,250.5 |
Net income | $ 3,953.6 | $ 4,338.4 | $ 8,075.3 |
Net income per share - basic (in dollars per share) | $ 37.05 | $ 40.51 | $ 76.40 |
Net income per share - diluted (in dollars per share) | $ 34.77 | $ 38.22 | $ 71.97 |
Weighted average shares outstanding - basic (in shares) | 106.7 | 107.1 | 105.7 |
Weighted average shares outstanding - diluted (in shares) | 113.7 | 113.5 | 112.2 |
Statements of Comprehensive Income | |||
Net income | $ 3,953.6 | $ 4,338.4 | $ 8,075.3 |
Other comprehensive income (loss), net of tax: | |||
Unrealized gain (loss) on debt securities | 158.2 | (213.6) | (56.4) |
Loss on foreign currency translation | (0.3) | 0.0 | 0.0 |
Unrealized gain on cash flow hedges | 0.0 | 1.0 | 0.9 |
Comprehensive income | 4,111.5 | 4,125.8 | 8,019.8 |
Net product sales | |||
Revenues: | |||
Revenue from contract with customer | 7,078.0 | 6,893.7 | 12,117.2 |
Expenses: | |||
Cost of goods sold and of collaboration and contract manufacturing | 932.1 | 800.0 | 1,773.1 |
Collaboration revenue | |||
Revenues: | |||
Revenue from contract with customer | 5,503.1 | 4,914.1 | 3,673.3 |
Other revenue | |||
Revenues: | |||
Revenue from contract with customer | 536.1 | 365.1 | 281.2 |
Cost of collaboration and contract manufacturing | |||
Expenses: | |||
Cost of goods sold and of collaboration and contract manufacturing | $ 883.7 | $ 760.4 | $ 664.4 |
CONSOLIDATED BALANCE SHEETS - USD ($) shares in Millions, $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 2,730.0 | $ 3,105.9 |
Marketable securities | 8,114.8 | 4,636.4 |
Accounts receivable, net | 5,667.3 | 5,328.7 |
Inventories | 2,580.5 | 2,401.9 |
Prepaid expenses and other current assets | 386.6 | 411.2 |
Total current assets | 19,479.2 | 15,884.1 |
Marketable securities | 5,396.5 | 6,591.8 |
Property, plant, and equipment, net | 4,146.4 | 3,763.0 |
Intangible assets, net | 1,038.6 | 915.5 |
Deferred tax assets | 2,575.4 | 1,723.7 |
Other noncurrent assets | 444.1 | 336.4 |
Total assets | 33,080.2 | 29,214.5 |
Current liabilities: | ||
Accounts payable | 606.6 | 589.2 |
Accrued expenses and other current liabilities | 2,357.9 | 2,074.2 |
Deferred revenue | 458.9 | 477.9 |
Total current liabilities | 3,423.4 | 3,141.3 |
Long-term debt | 1,982.9 | 1,981.4 |
Finance lease liabilities | 720.0 | 720.0 |
Deferred revenue | 126.7 | 69.8 |
Other noncurrent liabilities | 854.1 | 638.0 |
Total liabilities | 7,107.1 | 6,550.5 |
Commitments and contingencies | ||
Stockholders' equity: | ||
Preferred Stock, par value $.01 per share; 30.0 shares authorized; shares issued and outstanding - none | 0.0 | 0.0 |
Additional paid-in capital | 11,354.0 | 9,949.3 |
Retained earnings | 27,260.3 | 23,306.7 |
Accumulated other comprehensive loss | (80.9) | (238.8) |
Treasury Stock, at cost; 25.5 shares in 2023 and 22.6 shares in 2022 | (12,560.4) | (10,353.3) |
Total stockholders' equity | 25,973.1 | 22,664.0 |
Total liabilities and stockholders' equity | 33,080.2 | 29,214.5 |
Class A Stock | ||
Stockholders' equity: | ||
Common stock | $ 0.0 | $ 0.0 |
Common Stock, shares issued (in shares) | 1.8 | 1.8 |
Common Stock | ||
Stockholders' equity: | ||
Common stock | $ 0.1 | $ 0.1 |
Common Stock, shares issued (in shares) | 133.1 | 130.4 |